The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Compounds · Cagrilintide & amylin analogues · continued

What is genuinely unknown about long-term amylin agonism posts 91–92

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

JM
j.mwangiTL426 Jul 2026#91
SK
s.kimaniTL227 Jul 2026#92

On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have changed. Visual inspection is a weaker test here than usual.

Genuinely open to being wrong about this one.

1 like 1d

Suggested topics

TopicParticipantsRepliesViewsActivity
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists
Posting this under the heading it deserves: Nausea profile of amylin analogues compared with GLP-1 agonists Everything below is what sits behind that. Nausea profile of amylin analogues — I have the…
NEKCMALC+48 53 31k 13mo
Follow-up: What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism I have a specific reason for asking rather than idle curiosity, and the context is below. Putting the numbers in the first post, because a question…
NKSADM 2 25k 11mo
Why cagrilintide alone is discussed so much less than in combination — does this still hold?
Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Cagrilintide alone:…
SBKRSICPMN+27 31 1.2k 22h
Reading a combination trial: attributing effect to components
On the subject in the title: Reading a combination trial: attributing effect to components Working notes rather than a conclusion. Collecting what is known about reading a combination trial in one place,…
VMAHTTSVP 4 19k 11mo
Second pass at: Reading a combination trial: attributing effect to components
Second pass at: Reading a combination trial: attributing effect to components — setting out what I have, and where I think it stops being reliable. The question about Reading a combination trial that I…
ELPBLCMNBP+39 43 7.3k 12mo

Related topics — sharing the tags randomised trial, cagrilintide, cagrisema

TopicParticipantsRepliesViewsActivity
What a statistical analysis plan adds that the paper does not
What a statistical analysis plan adds that the paper does not — that is the question, and I have not found it answered plainly anywhere I have looked. Statistical analysis plan, and specifically the version…
AAZLHE 2 6.6k 10h
An 18-month record including the parts that went badly
An 18-month record including the parts that went badly — setting out what I have, and where I think it stops being reliable. Asking about 18-month record on behalf of the question I keep seeing asked badly,…
POBWBEPDED+77 81 17k 12h
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset
Posting this under the heading it deserves: The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Everything below is what sits behind that. Posting a small dataset on 2.5…
FBSERSGRI+12 16 11k 7mo
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
TKNMPMBSMC+74 80 17k 2d
The "under review" status pill and when a moderator applies it — a second dataset
The "under review" status pill and when a moderator applies it — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. A question about how this site should cite…
LVARMISLPM+50 54 1.4k 11mo